CLOV CLOVER HEALTH INV CORP

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024

FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024 financial results after market close on Tuesday, May 7, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 7, 2024, to discuss the Company’s business and financial results.

First Quarter 2024 Conference Call and Webcast Details:

  • What: Clover Health First Quarter 2024 Earnings Conference Call
  • When: Tuesday, May 7, 2024, at 5:00 p.m. Eastern Time
  • Dial In: To access the call via telephone please dial 800-579-2543 (for U.S. callers) or 785-424-1789 (for callers outside the U.S.) and enter the conference ID: CLOVQ124
  • Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of the Company’s website at for 12 months

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease.

Press Contact:

Andrew Still-Baxter

Investor Relations Contact:

Ryan Schmidt



EN
23/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health Reports Strong First Quarter 2024 Financial Results; Imp...

Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability First Quarter 2024 Insurance Revenue growth of 8% year-over-year First Quarter 2024 GAAP Net Loss from Continuing Operations of $23.2 million versus First Quarter 2023 loss of $79.7 million First Quarter Adjusted EBITDA profitability of $6.8 million versus prior period loss of $37.5 million Improves 2024 guidance to Insurance Revenue of $1.30 billion - $1.35 billion and Adjusted EBITDA profitability of $10 million - $30 million Maintains strong liqu...

 PRESS RELEASE

Clover Health to Participate at Bank of America 2024 Healthcare Confer...

Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads Conference FRANKLIN, Tenn., May 01, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences: CEO, Andrew Toy, and CFO, Peter Kuipers, will participate at the Bank of America 2024 Healthcare Conference on Wedne...

 PRESS RELEASE

Clover Health Announces Inducement Grant under Nasdaq Listing Rule 563...

Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) FRANKLIN, Tenn., April 30, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, announced today that effective April 29, 2024, the Talent and Compensation Committee of the Company’s Board of Directors granted a restricted stock unit award (the “RSUs”) to Peter Kuipers, who will be the Company’s new Chief Financial Officer effective as of the day afte...

 PRESS RELEASE

Clover Health to Report First Quarter 2024 Financial Results on May 7,...

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024 FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024 financial results after market close on Tuesday, May 7, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 7, 2024, to discuss the Company’s business and financial results. First Quarter 2024 Conference Call and Webcast Details: What: Clover Health First Quarter 2024 Earnings ...

 PRESS RELEASE

Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as ...

Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company, today announced the appointment of Peter Kuipers as Chief Financial Officer (“CFO”), effective as of the day after the filing of the Company’s Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024. With a wealth of experience and a proven track record in financial management, Mr. Kuipers will drive...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch